MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
Helius Medical Technologies P/E Ratio 2011-2026 | HSDT
Annual P/E Ratio Helius Medical Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -98.5 | -0.321 | -0.398 | -0.00518 | -0.629 | -1.14 | -2.64 | -5.95 | -6.98 | -10.8 | -14 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.00518 | -98.5 | -12.9 |
P/E Ratio of other stocks in the Medical devices industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
-0.813 | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
-3.16 | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
-50 | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
-0.142 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-47.3 | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
-0.108 | - | - | $ 10.2 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-45.2 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
-2.78 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-2.84 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
-12.4 | $ 13.75 | 1.18 % | $ 389 M | USA |
 |
Apollo Endosurgery
APEN
|
-10.1 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-14.4 | $ 8.24 | -0.24 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
-0.714 | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-0.707 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-0.00929 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-0.25 | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
-3.74 | $ 1.15 | 2.67 % | $ 19.5 M | USA |
 |
Cardiovascular Systems
CSII
|
-16.3 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
-54.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0578 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.25 | $ 0.41 | -3.91 % | $ 25.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-11 | $ 18.53 | 0.22 % | $ 435 M | USA |
 |
Delcath Systems
DCTH
|
121 | $ 11.47 | -1.88 % | $ 411 M | USA |
 |
Soliton, Inc.
SOLY
|
-15.7 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-875 | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
-15.7 | $ 78.78 | 2.08 % | $ 4.3 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
-31 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-10.6 | - | - | $ 462 M | USA |
 |
Pulmonx Corporation
LUNG
|
-1.35 | $ 1.51 | -1.63 % | $ 61.4 M | USA |
 |
Neovasc
NVCN
|
-27.2 | - | - | $ 111 M |  Canada |
 |
LENSAR
LNSR
|
-2.08 | $ 5.62 | -1.23 % | $ 67.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
-0.179 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
23.2 | $ 37.3 | 2.78 % | $ 315 M | USA |
 |
MiMedx Group
MDXG
|
16 | $ 3.72 | 0.13 % | $ 550 M | USA |
 |
Butterfly Network
BFLY
|
-12.3 | $ 5.37 | 4.88 % | $ 1.33 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-10.2 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
9.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
-2.17 | $ 1.41 | 6.82 % | $ 59 M | USA |
 |
Orthofix Medical
OFIX
|
-5.33 | $ 9.96 | 0.91 % | $ 394 M |  Curacao |
 |
GBS
GBS
|
-0.235 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
23.2 | $ 81.31 | -1.47 % | $ 11 B | USA |
 |
Insulet Corporation
PODD
|
73.4 | $ 156.21 | -2.13 % | $ 11 B | USA |
 |
Profound Medical Corp.
PROF
|
-3.9 | $ 6.6 | -3.22 % | $ 200 M | Canada |
 |
CONMED Corporation
CNMD
|
28 | $ 36.5 | -1.08 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
12.1 | $ 43.09 | 2.08 % | $ 1.27 B | USA |
 |
Integer Holdings Corporation
ITGR
|
29 | $ 93.28 | -0.87 % | $ 3.24 B | USA |
 |
Invacare Corporation
IVC
|
-1.17 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
45.5 | $ 86.42 | -1.28 % | $ 50.5 B | USA |
 |
Sintx Technologies
SINT
|
-0.666 | $ 2.11 | -0.24 % | $ 5.85 M | USA |